HCM Q3 2018 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$59M+2.6% YoY

Gross Profit

-$3M-5.3% margin

Operating Income

-$15M-25.1% margin

Net Income

-$26M-43.5% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+18.0%

Cash Flow

Operating Cash Flow

-$315,000

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$57M	+2.6%
Gross Profit	-$3M	-$8M	+60.6%
Operating Income	-$15M	-$19M	+20.8%
Net Income	-$26M	-$14M	-80.0%